In metabolism, we have identified the TBL1/TBLR1 transcriptional co-factor complex as a key regulator of hepatic lipid homeostasis and fatty liver disease with dysfunctional activities in mono- and multigenic diabetes, in both murine as well as human setting (Kulozik et al, 2011). Here, TBL1Y is linked to fatty liver disease.